Dystrophinopathies

Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach

Volumn , Issue , 2015, Pages 551-592

  Darras, Basil T ^a,b   Menache Starobinski, Caroline C ^c   Hinton, Veronica ^d   Kunkel, Louis M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Clinique et Fondation des Grangettes   (Switzerland)

^d Vagelos College of Physicians and Surgeons   (United States)

Author keywords

Becker muscular dystrophy; DMD gene; DMD gene mutations; DMD associated dilated cardiomyopathy; Duchenne muscular dystrophy; Dystrophin; Dystrophinopathies; Genetic counseling in dystrophinopathies; Manifesting DMD BMD carrier females

Indexed keywords

EID: 84938203211     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-417044-5.00030-5     Document Type: Chapter

References (371)

1. Meryon E. On granular and fatty degeneration of the voluntary muscles. Med Chir Trans 1852, 35:73.
2. Little W. On the nature and treatment of the deformities of the human frame: being a course of lectures delivered at the Royal Orthopaedic Hospital in 1843: With numerous notes and additions, to the present time 1853, Longman, Brown, Green and Longmans, London, pp. 14-16.
3. Duchenne de Boulogne GBA De l'electrisation Localisee et de Son Application a la Pathologie et a la Therapeutique 1861, Bailiere & Fils, Paris. 2nd ed.
4. Duchenne de Boulogne G.B.A. Recherches sur la paralysie musculaire pseudo-hypertrophique, ou paralysie myo-sclerosique. Neurological Classics 1973, 59-67. Reprint, Johnson, New York. R.H. Wilkins, I.A. Brody (Eds.).
5. Becker P.E., Kiener F. Eine neue X-chromosomale muskeldystrophie. Arch Psychiatr Z Neurol 1955, 193:427.
6. Walton J.N. On the inheritance of muscular dystrophy. Ann Hum Genet 1955, 20:1.
7. Greenstein R.M., Reardon M.P., Chan T.S., Middleton A.B., Mulivor R.A., Greene A.E., et al. An (X;11) translocation in a girl with Duchenne muscular dystrophy. Repository identification No. GM1695. Cytogenet Cell Genet 1980, 27(4):268.
8. Boyd Y., Buckle V., Holt S., Munro E., Hunter D., Craig I. Muscular dystrophy in girls with X; autosome translocations. J Med Genet 1986, 23(6):484-490.
9. Murray J.M., Davies K.E., Harper P.S., Meredith L., Mueller C.R., Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 1982, 300(5887):69-71.
10. Davies K.E., Pearson P.L., Harper P.S., Murray J.M., O'Brien T., Sarfarazi M., et al. Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res 1983, 11(8):2303-2312.
11. Francke U., Ochs H.D., de Martinville B., Giacalone J., Lindgren V., Disteche C., et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985, 37(2):250-267.
12. Kunkel L.M., Monaco A.P., Middlesworth W., Ochs H.D., Latt S.A. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci USA 1985, 82(14):4778-4782.
13. Kunkel L.M. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 1986, 73-77.
14. Monaco A.P., Neve R.L., Colleti-Feener C., Bertelson C.J., Kurnit D.M., Kunkel L.M. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986, 323:646-650.
15. Ray P.N., Belfall B., Duff C., Logan C., Kean V., Thompson M.W., et al. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 1985, 318(6047):672-675.
16. Burghes A.H., Logan C., Hu X., Belfall B., Worton R.G., Ray P.H. A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature 1987, 328:434-437.
17. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51(6):919-928.
18. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
19. Koenig M., Monaco A.P., Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 1988, 53(2):219-226.
20. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988, 333(6176):861-863.
21. Bonilla E., Samitt C.E., Miranda A.F., Hays A.P., Salviati G., DiMauro S., et al. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988, 54(4):447-452.
22. Zubrzycka-Gaarn E.E., Bulman D.E., Karpati G., Burghes A.H., Belfall B., Klamut H.J., et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988, 333:466-469.
23. Ferlini A., Neri M., Gualandi F. The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice. Neuromuscul Disord: NMD 2013, 23(1):4-14.
24. Hoffman E.P., Fischbeck K.H., Brown R.H., Johnson M., Medori R., Loike J.D., et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988, 318(21):1363-1368.
25. Nudel U., Robzyk K., Yaffe D. Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain. Nature 1988, 331(6157):635-638.
26. Nudel U., Zuk D., Einat P., Zeelon E., Levy Z., Neuman S., et al. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 1989, 337(6202):76-78.
27. Feener C.A., Koenig M., Kunkel L.M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 1989, 338(6215):509-511.
28. Boyce F.M., Beggs A.H., Feener C., Kunkel L.M. Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA 1991, 88(4):1276-1280.
29. Lederfein D., Levy Z., Augier N., Mornet D., Morris G., Fuchs O., et al. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci USA 1992, 89(12):5346-5350.
30. Ahn A.H., Kunkel L.M. The structural and functional diversity of dystrophin. Nature Genet 1993, 3:283-289.
31. Lidov H.G., Selig S., Kunkel L.M. Dp140: a novel 140kDa CNS transcript from the dystrophin locus. Hum Mol Genet 1995, 4(3):329-335.
32. Makover A., Zuk D., Breakstone J., Yaffe D., Nudel U. Brain-type and muscle-type promoters of the dystrophin gene differ greatly in structure. Neuromuscul Disord 1991, 1(1):39-45.
33. Rapaport D., Fuchs O., Nudel U., Yaffe D. Expression of the Duchenne muscular dystrophy gene products in embryonic stem cells and their differentiated derivatives. J Biol Chem 1992, 267(30):21289-21292.
34. Byers T.J., Lidov H.G., Kunkel L.M. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 1993, 4(1):77-81.
35. D'Souza V.N., Nguyen T.M., Morris G.E., Karges W., Pillers D.A., Ray P.N. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 1995, 4(5):837-842.
36. Bies R.D., Phelps S.F., Cortez M.D., Roberts R., Caskey C.T., Chamberlain J.S. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucleic Acids Res 1992, 20(7):1725-1731.
37. Lidov H.G., Byers T.J., Watkins S.C., Kunkel L.M. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 1990, 348(6303):725-728.
38. Gorecki D.C., Monaco A.P., Derry J.M., Walker A.P., Barnard E.A., Barnard P.J. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1992, 1(7):505-510.
39. Lidov H.G., Byers T.J., Kunkel L.M. The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. Neuroscience 1993, 54(1):167-187.
40. Bar S., Barnea E., Levy Z., Neuman S., Yaffe D., Nudel U. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J 1990, 272(2):557-560.
41. Rapaport D., Lederfein D., den Dunnen J.T., Grootscholten P.M., Van Ommen G.J., Fuchs O., et al. Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation 1992, 49(3):187-193.
42. Hugnot J.P., Gilgenkrantz H., Vincent N., Chafey P., Morris G.E., Monaco A.P., et al. Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci USA 1992, 89(16):7506-7510.
43. Byers T.J., Kunkel L.M., Watkins S.C. The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J Cell Biol 1991, 115(2):411-421.
44. Zubrzycka-Gaarn E.E., Hutter O.F., Karpati G., Klamut H.J., Bulman D.E., Hodges R.S., et al. Dystrophin is tightly associated with the sarcolemma of mammalian skeletal muscle fibers. Exp Cell Res 1991, 192(1):278-288.
45. Muscle Diseases 1999, Butterworth Heinemann, Boston. A.H.V. Schapira, R.C. Griggs (Eds.).
46. Campbell K.P., Kahl S.D. Association of dystrophin and an integral membrane glycoprotein. Nature 1989, 338(6212):259-262.
47. Ozawa E., Yoshida M., Hagiwara Y., Suzuki A., Mizuno Y., Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1990, 4:11711-11716.
48. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66:1121-1131.
49. Wewer U.M., Durkin M.E., Zhang X., Laursen H., Nielsen N.H., Towfighi J., et al. Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology 1995, 45:2099-2101.
50. Suzuki A., Yoshida M., Yamamoto H., Ozawa E. Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett 1992, 308(2):154-160.
51. Thompson T.G., Chan Y.M., Hack A.A., Brosius M., Rajala M., Lidov H.G., et al. Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. J Cell Biol 2000, 148(1):115-126.
52. Hillier B.J., Christopherson K.S., Prehoda K.E., Bredt D.S., Lim W.A. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 1999, 284(5415):812-815.
53. Koenig M., Beggs A.H., Moyer M., Scherpf S., Heindrich K., Bettecken T., et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989, 45(4):498-506.
54. Yan J., Feng J., Buzin C.H., Scaringe W., Liu Q., Mendell J.R., et al. Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD). Hum Mutat 2004, 23(2):203-204.
55. Dent K.M., Dunn D.M., von Niederhausern A.C., Aoyagi A.T., Kerr L., Bromberg M.B., et al. Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A 2005, 134(3):295-298.
56. Prior T.W., Bridgeman S.J. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn 2005, 7(3):317-326.
57. White S.J., Aartsma-Rus A., Flanigan K.M., Weiss R.B., Kneppers A.L., Lalic T., et al. Duplications in the DMD gene. Hum Mutat 2006, 27(9):938-945.
58. Flanigan K.M., Dunn D.M., von Niederhausern A., Soltanzadeh P., Gappmaier E., Howard M.T., et al. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat 2009, 30(12):1657-1666.
59. Takeshima Y., Yagi M., Okizuka Y., Awano H., Zhang Z., Yamauchi Y., et al. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J Hum Genet 2010, 55(6):379-388.
60. Dolinsky L.C., de Moura-Neto R.S., Falcao-Conceicao D.N. DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene. Neuromuscul Disord 2002, 12(9):845-848.
61. Flanigan K.M., von Niederhausern A., Dunn D.M., Alder J., Mendell J.R., Weiss R.B. Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet 2003, 72(4):931-939.
62. Hofstra R.M., Mulder I.M., Vossen R., de Koning-Gans P.A., Kraak M., Ginjaar I.B., et al. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Hum Mutat 2004, 23(1):57-66.
63. Bennett R.R., den Dunnen J., O'Brien K.F., Darras B.T., Kunkel L.M. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2001, 2(1):17.
64. Darras B.T., Blattner P., Harper J.F., Spiro A.J., Alter S., Francke U. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet 1988, 43(5):620-629.
65. Hoffman E.P., Kunkel L.M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 1989, 2(1):1019-1029.
66. Monaco A.P., Bertelson C.J., Liechti-Gallati S., Moser H., Kunkel L.M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988, 2(1):90-95.
67. Muhlemann O., Eberle A.B., Stalder L., Zamudio Orozco R. Recognition and elimination of nonsense mRNA. Biochim Biophys Acta 2008, 1779(9):538-549.
68. Malhotra S.B., Hart K.A., Klamut H.J., Thomas N.S., Bodrug S.E., Burghes A.H., et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 1988, 242(4879):755-759.
69. Beggs A.H., Hoffman E.P., Snyder J.R., Arahata K., Specht L., Shapiro F., et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet 1991, 49(1):54-67.
70. Hoffman E.P., Garcia C.A., Chamberlain J.S., Angelini C., Lupski J.R., Fenwick R. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy. Ann Neurol 1991, 30(4):605-610.
71. Bies R.D., Caskey C.T., Fenwick R. An intact cysteine-rich domain is required for dystrophin function. J Clin Invest 1992, 90(2):666-672.
72. Gangopadhyay S.B., Sherratt T.G., Heckmatt J.Z., Dubowitz V., Miller G., Shokeir M., et al. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet 1992, 51(3):562-570.
73. Helliwell T.R., Ellis J.M., Mountford R.C., Appleton R.E., Morris G.E. A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane. Am J Hum Genet 1992, 50(3):508-514.
74. Baumbach L.L., Chamberlain J.S., Ward P.A., Farwell N.J., Caskey C.T. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 1989, 39(4):465-474.
75. Winnard A.V., Klein C.J., Coovert D.D., Prior T., Papp A., Snyder P., et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet 1993, 2(6):737-744.
76. Chelly J., Gilgenkrantz H., Lambert M., Hamard G., Chafey P., Recan D., et al. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell 1990, 63(6):1239-1248.
77. Bushby K.M. Genetic and clinical correlations of Xp21 muscular dystrophy. J Inherit Metab Dis 1992, 15(4):551-564.
78. Prior T.W., Bartolo C., Papp A.C., Snyder P.J., Sedra M.S., Burghes A.H., et al. Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion. Neurology 1997, 48(2):486-488.
79. Nevo Y., Muntoni F., Sewry C., Legum C., Kutai M., Harel S., et al. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype. Isr Med Assoc J 2003, 5(2):94-97.
80. Love D.R., Flint T.J., Marsden R.F., Bloomfield J.F., Daniels R.J., Forrest S.M., et al. Characterization of deletions in the dystrophin gene giving mild phenotypes. Am J Med Genet 1990, 37(1):136-142.
81. Bushby K.M., Gardner-Medwin D., Nicholson L.V., Johnson M.A., Haggerty I.D., Cleghorn N.J., et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol 1993, 240(2):105-112.
82. England S.B., Nicholson L.V., Johnson M.A., Forrest S.M., Love D.R., Zubrzycka-Gaarn E.E., et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 1990, 343(6254):180-182.
83. Love D.R., Flint T.J., Genet S.A., Middleton-Price H.R., Davies K.E. Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. J Med Genet 1991, 28(12):860-864.
84. Muntoni F., Gobbi P., Sewry C., Sherratt T., Taylor J., Sandhu S.K., et al. Deletions in the 5' region of dystrophin and resulting phenotypes. J Med Genet 1994, 31(11):843-847.
85. Arahata K., Beggs A.H., Honda H., Ito S., Ishiura S., Tsukahara T., et al. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J Neurol Sci 1991, 101(2):148-156.
86. Nicholson L.V., Bushby K.M., Johnson M.A., den Dunnen J.T., Ginjaar I.B., van Ommen G.J. Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet 1992, 29(12):892-896.
87. Patria S.Y., Alimsardjono H., Nishio H., Takeshima Y., Nakamura H., Matsuo M. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation. Proc Assoc Am Physicians 1996, 108(4):308-314.
88. Winnard A.V., Mendell J.R., Prior T.W., Florence J., Burghes A.H. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet 1995, 56(1):158-166.
89. Ginjaar I.B., Kneppers A.L., v d Meulen J.D., Anderson L.V., Bremmer-Bout M., van Deutekom J.C., et al. Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family. Eur J Hum Genet: EJHG 2000, 8(10):793-796.
90. Shiga N., Takeshima Y., Sakamoto H., Inoue K., Yokota Y., Yokoyama M., et al. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J Clin Invest 1997, 100(9):2204-2210.
91. Gurvich O.L., Maiti B., Weiss R.B., Aggarwal G., Howard M.T., Flanigan K.M. DMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6. Hum Mutat 2009, 30(4):633-640.
92. Hoffman E.P., Kunkel L.M., Angelini C., Clarke A., Johnson M., Harris J.B. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology 1989, 39(8):1011-1017.
93. Karpati G. Recent developments in the biology of dystrophin and related molecules. Curr Opin Neurol Neurosurg 1992, 5(5):615-621.
94. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993, 90(8):3710-3714.
95. Hutter O.F. The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence. J Inherit Metab Dis 1992, 15(4):565-577.
96. Matsumura K., Tome F.M., Ionasescu V., Ervasti J.M., Anderson R.D., Romero N.B., et al. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J Clin Invest 1993, 92(2):866-871.
97. Menke A., Jockusch H. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 1991, 349(6304):69-71.
98. Matsumura K., Campbell K.P. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 1994, 17(1):2-15.
99. Carpenter S., Karpati G. Segmental necrosis and its demarcation in experimental micropuncture injury of skeletal muscle fibers. J Neuropathol Exp Neurol 1989, 48(2):154-170.
100. Spencer M.J., Croall D.E., Tidball J.G. Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem 1995, 270(18):10909-10914.
101. Karpati G., Carpenter S. Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am J Med Genet 1986, 25(4):653-658.
102. Kimura S., Sugino S., Ohtani Y., Matsukura M., Nishino I., Ikezawa M., et al. Muscle fiber immaturity and inactivity reduce myonecrosis in Duchenne muscular dystrophy. Ann Neurol 1998, 44(6):967-971.
103. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90(4):729-738.
104. Chandrasekharan K., Yoon J.H., Xu Y., deVries S., Camboni M., Janssen P.M., et al. A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med 2010, 2(42). 42ra54.
105. Sacco A., Mourkioti F., Tran R., Choi J., Llewellyn M., Kraft P., et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143(7):1059-1071.
106. Cohn R.D., Campbell K.P. Molecular basis of muscular dystrophies. Muscle Nerve 2000, 23(10):1456-1471.
107. Lai Y., Thomas G.D., Yue Y., Yang H.T., Li D., Long C., et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009, 119(3):624-635.
108. Percival J.M., Anderson K.N., Gregorevic P., Chamberlain J.S., Froehner S.C. Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLOS ONE 2008, 3(10):e3387.
109. Kobayashi Y.M., Rader E.P., Crawford R.W., Iyengar N.K., Thedens D.R., Faulkner J.A., et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008, 456(7221):511-515.
110. Heydemann A., McNally E. NO more muscle fatigue. J Clin Invest 2009, 119(3):448-450.
111. Khurana T.S., Watkins S.C., Chafey P., Chelly J., Tome F.M., Fardeau M., et al. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord 1991, 1(3):185-194.
112. Ohlendieck K., Ervasti J.M., Matsumura K., Kahl S.D., Leveille C.J., Campbell K.P. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 1991, 7(3):499-508.
113. Tinsley J.M., Blake D.J., Zuellig R.A., Davies K.E. Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 1994, 91(18):8307-8313.
114. Blake D.J., Tinsley J.M., Davies K.E. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 1996, 6(1):37-47.
115. Matsumura K., Ervasti J.M., Ohlendieck K., Kahl S.D., Campbell K.P. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992, 360(6404):588-591.
116. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 1996, 384(6607):349-353.
117. Love D.R., Byth B.C., Tinsley J.M., Blake D.J., Davies K.E. Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromuscul Disord 1993, 3(1):5-21.
118. Sewry C.A., Sansome A., Matsumura K., Campbell K.P., Dubowitz V. Deficiency of the 50kDa dystrophin-associated glycoprotein and abnormal expression of utrophin in two south Asian cousins with variable expression of severe childhood autosomal recessive muscular dystrophy. Neuromuscul Disord 1994, 4(2):121-129.
119. Chevron M.P., Echenne B., Demaille J. Absence of dystrophin and utrophin in a boy with severe muscular dystrophy [letter]. N Engl J Med 1994, 331(17):1162-1163.
120. Isaac C., Wright A., Usas A., Li H., Tang Y., Mu X., et al. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities. J Orthop Res 2013, 31(3):343-349.
121. Moorwood C., Khurana T.S. Duchenne muscular dystrophy drug discovery-the application of utrophin promoter activation screening. Expert Opin Drug Discov 2013, 8(5):569-581.
122. Amenta A.R., Yilmaz A., Bogdanovich S., McKechnie B.A., Abedi M., Khurana T.S., et al. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci USA 2011, 108(2):762-767.
123. Tinsley J.M., Fairclough R.J., Storer R., Wilkes F.J., Potter A.C., Squire S.E., et al. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLOS ONE 2011, 6(5):e19189.
124. Bakker E., Van Broeckhoven C., Bonten E.J., van de Vooren M.J., Veenema H., Van Hul W., et al. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 1987, 329(6139):554-556.
125. Darras B.T., Francke U. A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male. Nature 1987, 329(6139):556-558.
126. Myology 1994, McGraw-Hill, Inc, New York. 2nd ed. A.G. Engel, C. Franzini-Armstrong (Eds.).
127. van Essen A.J., Mulder I.M., van der Vlies P., van der Hout A.H., Buys C.H., Hofstra R.M., et al. Detection of point mutation in dystrophin gene reveals somatic and germline mosaicism in the mother of a patient with Duchenne muscular dystrophy. Am J Med Genet A 2003, 118(3):296-298.
128. Van Essen A.J., Abbs S., Bauget M., et al. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet 1992, 8:249-257.
129. Matthews P.M., Benjamin D., Van Bakel I., Squier M.V., Nicholson L.V., Sewry C., et al. Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers. Neuromuscul Disord 1995, 5(3):209-220.
130. Pena S.D., Karpati G., Carpenter S., Fraser F.C. The clinical consequences of X-chromosome inactivation: Duchenne muscular dystrophy in one of monozygotic twins. J Neurol Sci 1987, 79(3):337-344.
131. Quan F., Janas J., Toth-Fejel S., Johnson D.B., Wolford J.K., Popovich B.W. Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy. Am J Hum Genet 1997, 60(1):160-165.
132. Moat S.J., Bradley D.M., Salmon R., Clarke A., Hartley L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur J Hum Genet: EJHG 2013, 21(10):1049-1053.
133. Gardner-Medwin D. Mutation rate in Duchenne type of muscular dystrophy. J Med Genet 1970, 7(4):334-337.
134. Emery A.E. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br Med Bull 1980, 36(2):117-122.
135. Moser H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 1984, 66(1):17-40.
136. Bushby K.M., Thambyayah M., Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991, 337(8748):1022-1024.
137. Mostacciuolo M.L., Lombardi A., Cambissa V., Danieli G.A., Angelini C. Population data on benign and severe forms of X-linked muscular dystrophy. Hum Genet 1987, 75(3):217-220.
138. Nakagawa M., Nakahara K., Yoshidome H., Suehara M., Higuchi I., Fujiyama J., et al. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques. Neuroepidemiology 1991, 10(4):185-191.
139. Dooley J., Gordon K.E., Dodds L., MacSween J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr (Phila) 2010, 49(2):177-179.
140. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years-four states, 2007. MMWR Morbidity and mortality weekly report 2009;58(40):1119-22.
141. Muntoni F., Cau M., Ganau A., Congiu R., Arvedi G., Mateddu A., et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993, 329(13):921-925.
142. Beggs A.H. Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy [editorial]. Circulation 1997, 95(10):2344-2347.
143. Cox G.F., Kunkel L.M. Dystrophies and heart disease. Curr Opin Cardiol 1997, 12(3):329-343.
144. Towbin J.A. The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 1998, 10(1):131-139.
145. Angelini C., Fanin M., Pegoraro E., Freda M.P., Cadaldini M., Martinello F. Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes. Neuromuscul Disord 1994, 4(4):349-358.
146. Melacini P., Fanin M., Danieli G.A., Villanova C., Martinello F., Miorin M., et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996, 94(12):3168-3175.
147. Eiholzer U., Boltshauser E., Frey D., Molinari L., Zachmann M. Short stature: a common feature in Duchenne muscular dystrophy. Eur J Pediatr 1988, 147(6):602-605.
148. Marshall P.D., Galasko C.S. No improvement in delay in diagnosis of Duchenne muscular dystrophy [letter]. Lancet 1995, 345(8949):590-591.
149. Firth M., Gardner-Medwin D., Hosking G., Wilkinson E. Interviews with parents of boys suffering from Duchenne muscular dystrophy. Dev Med Child Neurol 1983, 25(4):466-471.
150. Li Q.X., Yang H., Zhang N., Xiao B., Bi F.F., Li J. Clinical and pathological features of 50 children with Duchenne's muscular dystrophy. Zhongguo Dang Dai Er Ke Za Zhi 2012, 14(10):746-750.
151. Bushby K.M. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet 1999, 8(10):1875-1882.
152. Zalaudek I., Bonelli R.M., Koltringer P., Reisecker F., Wagner K. Early diagnosis in Duchenne muscular dystrophy [letter]. Lancet 1999, 353(9168):1975.
153. Griggs R.C., Mendell J.R., Miller R.G. Evaluation and Treatment of Myopathies 1995, F.A. Davis Company, Philadelphia.
154. Ohtake T., Takahashi R., Nagashima T., Hirose K., Tanabe H. Sparing of the perineal muscles in muscular dystrophies [letter]. J Neurol 1989, 236(4):252.
155. Kaminski H.J., al-Hakim M., Leigh R.J., Katirji M.B., Ruff R.L. Extraocular muscles are spared in advanced Duchenne dystrophy. Ann Neurol 1992, 32(4):586-588.
156. Gardner-Medwin D. Clinical features and classification of the muscular dystrophies. Br Med Bull 1980, 36(2):109-115.
157. Allsop K.G., Ziter F.A. Loss of strength and functional decline in Duchenne's dystrophy. Arch Neurol 1981, 38(7):406-411.
158. Brooke M.H., Griggs R.C., Mendell J.R., Fenichel G.M., Shumate J.B. The natural history of Duchenne muscular dystrophy: a caveat for therapeutic trials. Trans Am Neurol Assoc 1981, 106:195-199.
159. McDonald C.M., Henricson E.K., Abresch R.T., Florence J.M., Eagle M., Gappmaier E., et al. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve 2013, 48(3):343-356.
160. Perlstein M.A. Deep-tendon reflexes in pseudohypertrophic muscular dystrophy: rate and order of loss. JAMA 1965, 193:540.
161. Dubowitz V. Muscle Biopsy: A Practical Approach 1985, Bailliere Tindall, London, pp. 289-339.
162. Inkley S.R., Oldenburg F.C., Vignos P.J. Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med 1974, 56(3):297-306.
163. Khirani S., Ramirez A., Aubertin G., Boule M., Chemouny C., Forin V., et al. Respiratory muscle decline in Duchenne muscular dystrophy. Pediatr Pulmonol 2013, http://dx.doi.org/10.1002/ppul.22847.
164. Passamano L., Taglia A., Palladino A., Viggiano E., D'Ambrosio P., Scutifero M., et al. Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients. Acta Myol 2012, 31(2):121-125.
165. Rall S., Grimm T. Survival in Duchenne muscular dystrophy. Acta Myol 2012, 31(2):117-120.
166. Eagle M., Bourke J., Bullock R., Gibson M., Mehta J., Giddings D., et al. Managing Duchenne muscular dystrophy-the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord: NMD 2007, 17(6):470-475.
167. Farah M.G., Evans E.B., Vignos P.J. Echocardiographic evaluation of left ventricular function in Duchenne's muscular dystrophy. Am J Med 1980, 69(2):248-254.
168. Finsterer J., Stollberger C. The heart in human dystrophinopathies. Cardiology 2003, 99(1):1-19.
169. Nigro G., Comi L.I., Politano L., Bain R.J. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990, 26(3):271-277.
170. James J., Kinnett K., Wang Y., Ittenbach R.F., Benson D.W., Cripe L. Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction. Neuromuscul Disord: NMD 2011, 21(7):462-467.
171. Hermans M.C., Pinto Y.M., Merkies I.S., de Die-Smulders C.E., Crijns H.J., Faber C.G. Hereditary muscular dystrophies and the heart. Neuromuscul Disord: NMD 2010, 20(8):479-492.
172. Lin J.J., Hwang M.S., Hsia S.H., Chung H.T., Chang Y.S., Lin K.L. Pericardial effusion with cardiac tamponade as a cardiac manifestation of Duchenne muscular dystrophy. Muscle Nerve 2009, 40(3):476-480.
173. Mavrogeni S., Papavasiliou A., Spargias K., Constandoulakis P., Papadopoulos G., Karanasios E., et al. Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study. BMC Neurol 2010, 10:33.
174. Cotton S., Voudouris N.J., Greenwood K.M. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol 2001, 43(7):497-501.
175. Pane M., Scalise R., Berardinelli A., D'Angelo G., Ricotti V., Alfieri P., et al. Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscul Disord: NMD 2013, 23(6):451-455.
176. Cyrulnik S.E., Fee R.J., De Vivo D.C., Goldstein E., Hinton V.J. Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr 2007, 150(5):474-478.
177. Smith R.A., Sibert J.R., Harper P.S. Early development of boys with Duchenne muscular dystrophy. Dev Med Child Neurol 1990, 32(6):519-527.
178. Cyrulnik S.E., Fee R.J., Batchelder A., Kiefel J., Goldstein E., Hinton V.J. Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc 2008, 14(5):853-861.
179. Billard C., Gillet P., Barthez M., Hommet C., Bertrand P. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol 1998, 40(1):12-20.
180. Whelan T.B. Neuropsychological performance of children with Duchenne muscular dystrophy and spinal muscle atrophy. Dev Med Child Neurol 1987, 29(2):212-220.
181. Hinton V.J., De Vivo D.C., Nereo N.E., Goldstein E., Stern Y. Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology 2000, 54(11):2127-2132.
182. Hinton V.J., De Vivo D.C., Nereo N.E., Goldstein E., Stern Y. Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of Duchenne muscular dystrophy. J Int Neuropsychol Soc 2001, 7(1):45-54.
183. Hinton V.J., De Vivo D.C., Fee R., Goldstein E., Stern Y. Investigation of poor academic achievement in children with Duchenne muscular dystrophy. Learn Disabil Res Pract 2004, 19(3):146-154.
184. Hinton V.J., Fee R.J., Goldstein E.M., De Vivo D.C. Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol 2007, 49(2):123-128.
185. Hendriksen J.G., Vles J.S. Are males with Duchenne muscular dystrophy at risk for reading disabilities?. Pediatr Neurol 2006, 34(4):296-300.
186. Wingeier K., Giger E., Strozzi S., Kreis R., Joncourt F., Conrad B., et al. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci 2011, 18(1):90-95.
187. Dorman C., Hurley A.D., D'Avignon J. Language and learning disorders of older boys with Duchenne muscular dystrophy. Dev Med Child Neurol 1988, 30(3):316-327.
188. Lorusso M.L., Civati F., Molteni M., Turconi A.C., Bresolin N., D'Angelo M.G. Specific profiles of neurocognitive and reading functions in a sample of 42 Italian boys with Duchenne Muscular Dystrophy. Child Neuropsychol 2013, 19(4):350-369.
189. de Moura M.C., Do Valle L.E., Resende M.B., Pinto K.O. Visuospatial attention disturbance in Duchenne muscular dystrophy. Dev Med Child Neurol 2010, 52(2):e10-e15.
190. Mento G., Tarantino V., Bisiacchi P.S. The neuropsychological profile of infantile Duchenne muscular dystrophy. Clin Neuropsychol 2011, 25(8):1359-1377.
191. Donders J., Taneja C. Neurobehavioral characteristics of children with Duchenne muscular dystrophy. Child Neuropsychol 2009, 15(3):295-304.
192. Hendriksen J.G., Vles J.S. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol 2008, 23(5):477-481.
193. Darke J., Bushby K., Le Couteur A., McConachie H. Survey of behaviour problems in children with neuromuscular diseases. Eur J Paediatr Neurol 2006, 10(3):129-134.
194. Hinton V.J., Nereo N.E., Fee R.J., Cyrulnik S.E. Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 2006, 27(6):470-476.
195. Wu J.Y., Kuban K.C., Allred E., Shapiro F., Darras B.T. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol 2005, 20(10):790-795.
196. Hinton V.J., Cyrulnik S.E., Fee R.J., Batchelder A., Kiefel J.M., Goldstein E.M., et al. Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol 2009, 41(5):339-346.
197. Fitzpatrick C., Barry C., Garvey C. Psychiatric disorder among boys with Duchenne muscular dystrophy. Dev Med Child Neurol 1986, 28(5):589-595.
198. Fee R.J., Hinton V.J. Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr 2011, 32(9):644-650.
199. Elsenbruch S., Schmid J., Lutz S., Geers B., Schara U. Self-reported quality of life and depressive symptoms in children, adolescents, and adults with Duchenne muscular dystrophy: a cross-sectional survey study. Neuropediatrics 2013, 44(5):257-264.
200. Rahbek J., Werge B., Madsen A., Marquardt J., Steffensen B.F., Jeppesen J. Adult life with Duchenne muscular dystrophy: observations among an emerging and unforeseen patient population. Pediatr Rehabil 2005, 8(1):17-28.
201. Moizard M.P., Billard C., Toutain A., Berret F., Marmin N., Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy?. Am J Med Genet 1998, 80(1):32-41.
202. Felisari G., Martinelli Boneschi F., Bardoni A., Sironi M., Comi G.P., Robotti M., et al. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 2000, 55(4):559-564.
203. D'Angelo M.G., Lorusso M.L., Civati F., Comi G.P., Magri F., Del Bo R., et al. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatric neurology 2011, 45(5):292-299.
204. Bushby K., Finkel R., Birnkrant D.J., Case L.E., Clemens P.R., Cripe L., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9(1):77-93.
205. Rosman N.P., Kakulas B.A. Mental deficiency associated with muscular dystrophy. A neuropathological study. Brain 1966, 89(4):769-788.
206. Dubowitz V., Crome L. The central nervous system in Duchenne muscular dystrophy. Brain 1969, 92(4):805-808.
207. Daoud F., Angeard N., Demerre B., Martie I., Benyaou R., Leturcq F., et al. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet 2009, 18(20):3779-3794.
208. Taylor P.J., Betts G.A., Maroulis S., Gilissen C., Pedersen R.L., Mowat D.R., et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLOS ONE 2010, 5(1):e8803.
209. Barohn R.J., Levine E.J., Olson J.O., Mendell J.R. Gastric hypomotility in Duchenne's muscular dystrophy. N Engl J Med 1988, 319(1):151-158.
210. Chung B.C., Park H.J., Yoon S.B., Lee H.W., Kim K.W., Lee S.I., et al. Acute gastroparesis in Duchenne's muscular dystrophy. Yonsei Med J 1998, 39(2):175-179.
211. Larson C.M., Henderson R.C. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 2000, 20(1):71-74.
212. Parker A.E., Robb S.A., Chambers J., Davidson A.C., Evans K., O'Dowd J., et al. Analysis of an adult Duchenne muscular dystrophy population. QJM 2005, 98(10):729-736.
213. McDonald D.G., Kinali M., Gallagher A.C., Mercuri E., Muntoni F., Roper H., et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 2002, 44(10):695-698.
214. Hsu J.D., Quinlivan R. Scoliosis in Duchenne muscular dystrophy (DMD). Neuromuscul Disord: NMD 2013, 23(8):611-617.
215. Velasco M.V., Colin A.A., Zurakowski D., Darras B.T., Shapiro F. Posterior spinal fusion for scoliosis in Duchenne muscular dystrophy diminishes the rate of respiratory decline. Spine 2007, 32(4):459-465.
216. Alexander W.M., Smith M., Freeman B.J., Sutherland L.M., Kennedy J.D., Cundy P.J. The effect of posterior spinal fusion on respiratory function in Duchenne muscular dystrophy. Eur Spine J 2013, 22(2):411-416.
217. Karpati G., Watters G.V. Adverse anaesthetic reactions in Duchenne dystrophy. Excerpta Medica ICS 1980, 527:206.
218. Rosenberg H., Heiman-Patterson T. Duchenne's muscular dystrophy and malignant hyperthermia: another warning [letter]. Anesthesiology 1983, 59(4):362.
219. Sethna N.F., Rockoff M.A., Worthen H.M., Rosnow J.M. Anesthesia-related complications in children with Duchenne muscular dystrophy. Anesthesiology 1988, 68(3):462-465.
220. Nathan A., Ganesh A., Godinez R.I., Nicolson S.C., Greeley W.J. Hyperkalemic cardiac arrest after cardiopulmonary bypass in a child with unsuspected Duchenne muscular dystrophy. Anesth Analg 2005, 100(3):672-674.
221. Willner J., Nakagawa M., Wood D. Drug-induced fiber necrosis in Duchenne dystrophy. Ital J Neurol Sci 1984, 5(Suppl. 3):117.
222. Emery A.E., Skinner R. Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 1976, 10(4):189-201.
223. Ringel S.P., Carroll J.E., Schold S.C. The spectrum of mild X-linked recessive muscular dystrophy. Arch Neurol 1977, 34(7):408-416.
224. Bradley W.G., Jones M.Z., Mussini J.M., Fawcett P.R. Becker-type muscular dystrophy. Muscle Nerve 1978, 1(2):111-132.
225. Bushby K.M., Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. J Neurol 1993, 240(2):98-104.
226. Specht L, Shapiro F. Boys with Duchenne and Becker muscular dystrophy are clinically indistinguishable at presentation [abstr]. Ann Neurol 1990;28:443.
227. Emery A.E.H. Muscular dystrophy, benign X-linked (Becker). Handbook of Clinical Neurology 1982, 86-88. North Holland, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
228. de Visser M., Bakker E., Defesche J.C., Bolhuis P.A., van Ommen G.J. An unusual variant of Becker muscular dystrophy. Ann Neurol 1990, 27(5):578-581.
229. Doriguzzi C., Palmucci L., Mongini T., Chiado-Piat L., Restagno G., Ferrone M. Exercise intolerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy. J Neurol 1993, 240(5):269-271.
230. Samaha F.J., Quinlan J.G. Myalgia and cramps: dystrophinopathy with wide-ranging laboratory findings. J Child Neurol 1996, 11(1):21-24.
231. Yazawa M., Ikeda S., Owa M., Haruta S., Yanagisawa N., Tanaka E., et al. A family of Becker's progressive muscular dystrophy with severe cardiomyopathy. Eur Neurol 1987, 27(1):13-19.
232. Casazza F., Brambilla G., Salvato A., Morandi L., Gronda E., Bonacina E. Cardiac transplantation in Becker muscular dystrophy. J Neurol 1988, 235(8):496-498.
233. Donofrio P.D., Challa V.R., Hackshaw B.T., Mills S.A., Cordell A.R. Cardiac transplantation in a patient with muscular dystrophy and cardiomyopathy. Arch Neurol 1989, 46(6):705-707.
234. Finsterer J., Bittner R.E., Grimm M. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement. Neuromuscul Disord 1999, 9(8):598-600.
235. Doo K.H., Ryu H.W., Kim S.S., Lim B.C., Hwang H., Kim K.J., et al. A case of Becker muscular dystrophy with early manifestation of cardiomyopathy. Korean J Pediatr 2012, 55(9):350-353.
236. Kaspar R.W., Allen H.D., Ray W.C., Alvarez C.E., Kissel J.T., Pestronk A., et al. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2009, 2(6):544-551.
237. Norman A.M., Thomas N.S., Kingston H.M., Harper P.S. Becker muscular dystrophy: correlation of deletion type with clinical severity. J Med Genet 1990, 27(4):236-239.
238. Heald A., Anderson L.V., Bushby K.M., Shaw P.J. Becker muscular dystrophy with onset after 60 years. Neurology 1994, 44(12):2388-2390.
239. Yazaki M., Yoshida K., Nakamura A., Koyama J., Nanba T., Ohori N., et al. Clinical characteristics of aged Becker muscular dystrophy patients with onset after 30 years. Eur Neurol 1999, 42(3):145-149.
240. Bosone I., Bortolotto S., Mongini T., Doriguzzi C., Chiado-Piat L., Ugo I., et al. Late onset and very mild course of Xp21 Becker type muscular dystrophy. Clin Neuropathol 2001, 20(5):196-199.
241. Brooke M.H., Fenichel G.M., Griggs R.C., Mendell J.R., Moxley R., Miller J.P., et al. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983, 6(2):91-103.
242. Berko B.A., Swift M. X-linked dilated cardiomyopathy. N Engl J Med 1987, 316(19):1186-1191.
243. Towbin J.A., Hejtmancik J.F., Brink P., Gelb B., Zhu X.M., Chamberlain J.S., et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993, 87(6):1854-1865.
244. Palmucci L., Doriguzzi C., Mongini T., Chiado-Piat L., Restagno G., Carbonara A., et al. Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy. J Neurol Sci 1992, 111(2):218-221.
245. Yoshida K., Ikeda S., Nakamura A., Kagoshima M., Takeda S., Shoji S., et al. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 1993, 16(11):1161-1166.
246. Ferlini A., Sewry C., Melis M.A., Mateddu A., Muntoni F. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 1999, 9(5):339-346.
247. Neri M., Torelli S., Brown S., Ugo I., Sabatelli P., Merlini L., et al. Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human. Neuromuscul Disord: NMD 2007, 17(11-12):913-918.
248. Saito M., Kawai H., Akaike M., Adachi K., Nishida Y., Saito S. Cardiac dysfunction with Becker muscular dystrophy. Am Heart J 1996, 132(3):642-647.
249. Milasin J., Muntoni F., Severini G.M., Bartoloni L., Vatta M., Krajinovic M., et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyoathy. Hum Mol Genet 1996, 5:73-79.
250. Yoshida K., Nakamura A., Yazaki M., Ikeda S., Takeda S. Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum Mol Genet 1998, 7(7):1129-1132.
251. Neri M., Valli E., Alfano G., Bovolenta M., Spitali P., Rapezzi C., et al. The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5'. X-linked dilated cardiomyopathy. BMC Med Genet 2012, 13:20.
252. Muntoni F., Melis M.A., Ganau A., Dubowitz V. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family witih X-linked dilated cardiomyopathy. Am J Hum Genet 1995, 56:151-157.
253. Muntoni F., Wilson L., Marrosu G., Marrosu M.G., Cianchetti C., Mestroni L., et al. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 1995, 96:693-699.
254. Ortiz-Lopez R., Li H., Su J., Goytia V., Towbin J.A. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 1997, 95(10):2434-2440.
255. Gavillet B., Rougier J.S., Domenighetti A.A., Behar R., Boixel C., Ruchat P., et al. Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res 2006, 99(4):407-414.
256. Palmucci L., Mongini T., Chiado-Piat L., Doriguzzi C., Fubini A. Dystrophinopathy expressing as either cardiomyopathy or Becker dystrophy in the same family. Neurology 2000, 54(2):529-530.
257. Gospe S.M., Lazaro R.P., Lava N.S., Grootscholten P.M., Scott M.O., Fischbeck K.H. Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene. Neurology 1989, 39(10):1277-1280.
258. Gold R., Kress W., Meurers B., Meng G., Reichmann H., Muller C.R. Brief communication: Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis. Muscle Nerve 1992, 15:214-218.
259. Figarella-Branger D., Baeta Machado A.M., Putzu G.A., Malzac P., Voelckel M.A., Pellissier J.F. Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies. Acta Neuropathol 1997, 94(1):48-53.
260. Melis M.A., Cau M., Muntoni F., Mateddu A., Galanello R., Boccone L., et al. Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. Eur J Paediatr Neurol 1998, 2(5):255-261.
261. Saengpattrachai M., Ray P.N., Hawkins C.E., Berzen A., Banwell B.L. Grandpa and I have dystrophinopathy?: approach to asymptomatic hyperCKemia. Pediatr Neurol 2006, 35(2):145-149.
262. Suminaga R., Takeshima Y., Wada H., Yagi M., Matsuo M. C-terminal truncated dystrophin identified in skeletal muscle of an asymptomatic boy with a novel nonsense mutation of the dystrophin gene. Pediatr Res 2004, 56(5):739-743.
263. Moser H., Emery A.E. The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 1974, 5(4):271-284.
264. Norman A., Harper P. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales. Clin Genet 1989, 36(1):31-37.
265. Juan-Mateu J., Rodriguez M.J., Nascimento A., Jimenez-Mallebrera C., Gonzalez-Quereda L., Rivas E., et al. Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy. Orphanet J Rare Dis 2012, 7:82.
266. Olson B.J., Fenichel G.M. Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy. Arch Neurol 1982, 39(6):378-380.
267. Hoogerwaard E.M., Bakker E., Ippel P.F., Oosterwijk J.C., Majoor-Krakauer D.F., Leschot N.J., et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999, 353(9170):2116-2119.
268. Hoogerwaard E.M., van der Wouw P.A., Wilde A.A., Bakker E., Ippel P.F., Oosterwijk J.C., et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999, 9(5):347-351.
269. Kamakura K., Kawai M., Arahata K., Koizumi H., Watanabe K., Sugita H. A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms. J Neurol 1990, 237(8):483-485.
270. Schade van Westrum S.M., Hoogerwaard E.M., Dekker L., Standaar T.S., Bakker E., Ippel P.F., et al. Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology 2011, 77(1):62-66.
271. Nolan M.A., Jones O.D., Pedersen R.L., Johnston H.M. Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies. Neuromuscul Disord 2003, 13(2):129-132.
272. Hoffman E.P., Arahata K., Minetti C., Bonilla E., Rowland L.P. Dystrophinopathy in isolated cases of myopathy in females. Neurology 1992, 42(5):967-975.
273. Muntoni F., Mateddu A., Cianchetti C., Marrosu M.G., Clerk A., Cau M., et al. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. J Neurol Neurosurg Psychiatry 1993, 56(1):26-31.
274. Katayama Y., Tran V.K., Hoan N.T., Zhang Z., Goji K., Yagi M., et al. Co-occurrence of mutations in both dystrophin- and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy. Hum Genet 2006, 119(5):516-519.
275. Sumita D.R., Vainzof M., Campiotto S., Cerqueira A.M., Canovas M., Otto P.A., et al. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers. Am J Med Genet 1998, 80(4):356-361.
276. Soltanzadeh P., Friez M.J., Dunn D., von Niederhausern A., Gurvich O.L., Swoboda K.J., et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord: NMD 2010, 20(8):499-504.
277. Pegoraro E., Schimke R.N., Arahata K., Hayashi Y., Stern H., Marks H., et al. Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females. Am J Hum Genet 1994, 54(6):989-1003.
278. Viggiano E., Picillo E., Cirillo A., Politano L. Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers, non-manifesting carriers and related daughters. Clin Genet 2013, 84(3):265-270.
279. Lupski J.R., Garcia C.A., Zoghbi H.Y., Hoffman E.P., Fenwick R.G. Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy. Am J Med Genet 1991, 40(3):354-364.
280. Zneimer S.M., Schneider N.R., Richards C.S. In situ hybridization shows direct evidence of skewed X inactivation in one of monozygotic twin females manifesting Duchenne muscular dystrophy. Am J Med Genet 1993, 45(5):601-605.
281. Fujii K., Minami N., Hayashi Y., Nishino I., Nonaka I., Tanabe Y., et al. Homozygous female Becker muscular dystrophy. Am J Med Genet A 2009, 149A(5):1052-1055.
282. Schwartz M., Hertz J.M., Sveen M.L., Vissing J. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. Neurology 2005, 64(9):1635-1637.
283. Zacharias A.S., Wagener M.E., Warren S.T., Hopkins L.C. Emery-Dreifuss muscular dystrophy. Semin Neurol 1999, 19(1):67-79.
284. Raffaele Di Barletta M., Ricci E., Galluzzi G., Tonali P., Mora M., Morandi L., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2000, 66(4):1407-1412.
285. Arikawa E., Ishihara T., Nonaka I., Sugita H., Arahata K. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy. J Neurol Sci 1991, 105(1):79-87.
286. Prelle A., Medori R., Moggio M., Chan H.W., Gallanti A., Scarlato G., et al. Dystrophin deficiency in a case of congenital myopathy. J Neurol 1992, 239(2):76-78.
287. Chanprasert S., Wang J., Weng S.W., Enns G.M., Boue D.R., Wong B.L., et al. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. Mol Genet Metab 2013, 110(1-2):153-161.
288. Vu T.H., Sciacco M., Tanji K., Nichter C., Bonilla E., Chatkupt S., et al. Clinical manifestations of mitochondrial DNA depletion. Neurology 1998, 50(6):1783-1790.
289. McMillan H.J., Gregas M., Darras B.T., Kang P.B. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy. Pediatrics 2011, 127(1):e132-e136.
290. Morse R.P., Rosman N.P. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities. J Pediatr 1993, 122(2):254-256.
291. Mestroni L., Rocco C., Gregori D., Sinagra G., Di Lenarda A., Miocic S., et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 1999, 34(1):181-190.
292. Watkins H., Ashrafian H., Redwood C. Inherited cardiomyopathies. N Engl J Med 2011, 364(17):1643-1656.
293. D'Adamo P., Fassone L., Gedeon A., Janssen E.A., Bione S., Bolhuis P.A., et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997, 61(4):862-867.
294. Yen T.Y., Hwu W.L., Chien Y.H., Wu M.H., Lin M.T., Tsao L.Y., et al. Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and a literature review. Eur J Pediatr 2008, 167(8):941-944.
295. Darras BT, Miller DT, Urion DK. Dystrophinopathies. 2000 Sep 5 [Updated 2011 Nov 23]. In: Pagon RA, Adam MP, Bird TD, et al., editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013. Available from: <>. http://www.ncbi.nlm.nih.gov/books/NBK1119/.
296. Rosalki S.B. Serum enzymes in disease of skeletal muscle. Clin Lab Med 1989, 9(4):767-781.
297. Zatz M., Rapaport D., Vainzof M., Passos-Bueno M.R., Bortolini E.R., Pavanello Rde C., et al. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. J Neurol Sci 1991, 102(2):190-196.
298. Kuhn E., Fiehn W., Schroder J.M., Assmus H., Wagner A. Early myocardial disease and cramping myalgia in Becker-type muscular dystrophy: a kindred. Neurology 1979, 29(8):1144-1149.
299. Pearson C.M. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med 1957, 256:1069-1075.
300. Fowler W.M., Pearson C.M. Diagnostic and prognostic significance of serum enzymes. I. Muscular dystrophy. Arch Phys Med 1964, 45:117-124.
301. Munsat T.L., Baloh R., Pearson C.M., Fowler W. Serum enzyme alterations in neuromuscular disorders. JAMA 1973, 226(13):1536-1543.
302. Griggs R.C., Mendell J.R., Brooke M.H., Fenichel G.M., Miller J.P., Province M., et al. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve 1985, 8(1):60-67.
303. Dawson D.M., Fine I.H. Creatin kinase in human tissues. Arch Neurol 1967, 16(2):175-180.
304. Goto I., Nagamine M., Katsuki S. Creatine phosphokinase isozymes in muscles. Human fetus and patients. Arch Neurol 1969, 20(4):422-429.
305. Somer H., Dubowitz V., Donner M. Creatine kinase isoenzymes in neuromuscular diseases. J Neurol Sci 1976, 29(2-4):129-136.
306. Somer H., Donner M., Murros J., Konttinen A. A serum isozyme study in muscular dystrophy. Particular reference to creatine kinase, aspartate aminotransferase, and lactic acid dehydrogenase isozymes. Arch Neurol 1973, 29(5):343-345.
307. Goedde H.W., Christ I., Benkmann H.G., Beckmann R., Lang H. Creatine kinase isoenzyme patterns in Duchenne muscular dystrophy. Clin Genet 1978, 14(5):257-260.
308. Takahashi K., Shutta K., Matsuo B., Takai T., Takao H., Imura H. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy. Clin Chim Acta 1977, 75(3):435-442.
309. Tzvetanova E. Serum creatine kinase isoenzymes in progressive muscular dystrophy. Enzyme 1978, 23(4):238-245.
310. Wolf P.L. Abnormalities in serum enzymes in skeletal muscle diseases. Am J Clin Pathol 1991, 95(3):293-296.
311. Ando T., Shimizu T., Kato T., Ohsawa M., Fukuyama Y. Myoglobinemia in children with progressive muscular dystrophy. Clin Chim Acta 1978, 85(1):17-22.
312. Kagen L.J., Moussavi S., Miller S.L., Tsairis P. Serum myoglobin in muscular dystrophy. Muscle Nerve 1980, 3(3):221-226.
313. Florence J.M., Fox P.T., Planer G.J., Brooke M.H. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?. Neurology 1985, 35(5):758-761.
314. Engel A.G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984, 16(2):209-215.
315. Bell C.D., Conen P.E. Change in fiber size in Duchenne muscular dystrophy. Neurology 1967, 17(9):902-913.
316. Schiaffino S., Gorza L., Dones I., Cornelio F., Sartore S. Fetal myosin immunoreactivity in human dystrophic muscle. Muscle Nerve 1986, 9(1):51-58.
317. Karpati G., Carpenter S., Morris G.E., Davies K.E., Guerin C., Holland P. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 1993, 52(2):119-128.
318. Watkins S.C., Cullen M.J. Histochemical fibre typing and ultrastructure of the small fibres in Duchenne muscular dystrophy. Neuropathol Appl Neurobiol 1985, 11(6):447-460.
319. Kaido M., Arahata K., Hoffman E.P., Nonaka I., Sugita H. Muscle histology in Becker muscular dystrophy. Muscle Nerve 1991, 14(11):1067-1073.
320. Uchino M., Araki S., Miike T. Correlative study of the incidence of opaque, necrotic and regenerative fibers in Duchenne dystrophy. Acta Neuropathol 1988, 75(3):308-312.
321. Bodensteiner J.B., Engel A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 1978, 28(5):439-446.
322. Nonaka I., Sugita H. Muscle pathology of Duchenne dystrophy, with particular reference to "opaque fibers". Adv Neurol Sci 1980, 24:718.
323. Cornelio F., Dones I. Muscle fiber degeneration and necrosis in muscular dystrophy and other muscle diseases: cytochemical and immunocytochemical data. Ann Neurol 1984, 16(6):694-701.
324. Momma K., Noguchi S., Malicdan M.C., Hayashi Y.K., Minami N., Kamakura K., et al. Rimmed vacuoles in Becker muscular dystrophy have similar features with inclusion myopathies. PLOS ONE 2012, 7(12):e52002.
325. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984, 16(2):193-208.
326. Stephens H.R., Duance V.C., Dunn M.J., Bailey A.J., Dubowitz V. Collagen types in neuromuscular diseases. J Neurol Sci 1982, 53(1):45-62.
327. Mokri B., Engel A.G. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 1975, 25(12):1111-1120.
328. Carpenter S., Karpati G. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 1979, 102(1):147-161.
329. Bulman D.E., Murphy E.G., Zubrzycka-Gaarn E.E., Worton R.G., Ray P.N. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet 1991, 48(2):295-304.
330. Voit T., Stuettgen P., Cremer M., Goebel H.H. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and Western blot. Neuropediatrics 1991, 22(3):152-162.
331. Winnard A.V., Jia-Hsu Y., Gibbs R.A., Mendell J.R., Burghes A.H. Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient. Hum Mol Genet 1992, 1(8):645-646.
332. Klein C.J., Coovert D.D., Bulman D.E., Ray P.N., Mendell J.R., Burghes A.H. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 1992, 50(5):950-959.
333. Nicholson L.V., Johnson M.A., Gardner-Medwin D., Bhattacharya S., Harris J.B. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol 1990, 80(3):239-250.
334. Nguyen T.M., Morris G.E. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy. Am J Hum Genet 1993, 52(6):1057-1066.
335. Yamamoto H., Brengman J.M., McCormick D.J., Nishino H., Engel A.G. Dystrophin deficiency examined by combined PCR, immunoblot and immunostain analysis [abstr]. Neurology 1993, 43(Suppl.):A293-A294.
336. Nicholson L.V., Johnson M.A., Bushby K.M., Gardner-Medwin D., Curtis A., Ginjaar I.B., et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet 1993, 30(9):728-736.
337. Ikeya K., Saito K., Hayashi K., Tanaka H., Hagiwara Y., Yoshida M., et al. Molecular genetic and immunological analysis of dystrophin of a young patient with X-linked muscular dystrophy. Am J Med Genet 1992, 43(3):580-587.
338. Gold R., Kress W., Reichmann H., Muller C.R. The use of monoclonal antibodies in diagnostic tests for Becker and Duchenne muscular dystrophy. J Neurol 1993, 240(1):21-24.
339. Hoogerwaard E.M., Ginjaar I.B., Bakker E., de Visser M. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Neurology 2005, 65(12):1984-1986.
340. Bonilla E., Schmidt B., Samitt C.E., Miranda A.F., Hays A.P., de Oliveira A.B., et al. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy. Am J Pathol 1988, 133(3):440-445.
341. Arahata K., Ishihara T., Kamakura K., Tsukahara T., Ishiura S., Baba C., et al. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med 1989, 320(3):138-142.
342. Morandi L., Mora M., Gussoni E., Tedeschi S., Cornelio F. Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: correlation with intracellular calcium and albumin. Ann Neurol 1990, 28(5):674-679.
343. Vainzof M., Pavanello R.C., Pavanello I., Tsanaclis A.M., Levy J.A., Passos-Bueno M.R., et al. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages. Neuromuscul Disord 1991, 1(3):177-183.
344. Muntoni F., Mateddu A., Marrosu M.G., Cau M., Congiu R., Melis M.A., et al. Variable dystrophin expression in different muscles of a Duchenne muscular dystrophy carrier. Clin Genet 1992, 42(1):35-38.
345. Mercier S., Toutain A., Toussaint A., Raynaud M., de Barace C., Marcorelles P., et al. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet: EJHG 2013, 21(8):855-863.
346. Clerk A., Rodillo E., Heckmatt J.Z., Dubowitz V., Strong P.N., Sewry C.A. Characterisation of dystrophin in carriers of Duchenne muscular dystrophy. J Neurol Sci 1991, 102(2):197-205.
347. Bernier F.P., Greenberg C.R., Halliday W.C., Wrogemann K. Single-blind study of dystrophin staining in carriers of Duchenne muscular dystrophy. Can J Neurol Sci 1993, 20(1):44-47.
348. Nicholson L.V., Johnson M.A., Bushby K.M., Gardner-Medwin D., Curtis A., Ginjaar I.B., et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients. J Med Genet 1993, 30(9):737-744.
349. Arikawa E., Hoffman E.P., Kaido M., Nonaka I., Sugita H., Arahata K. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology 1991, 41(9):1491-1496.
350. Beggs A.H., Hoffman E.P., Kunkel L.M. Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions. Am J Med Genet 1992, 44(3):378-381.
351. Cox G.A., Cole N.M., Matsumura K., Phelps S.F., Hauschka S.D., Campbell K.P., et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 1993, 364:673-675.
352. Nicholson L.V., Johnson M.A., Bushby K.M., Gardner-Medwin D., Curtis A., Ginjaar I.B., et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis. J Med Genet 1993, 30(9):745-751.
353. Kesari A., Pirra L.N., Bremadesam L., McIntyre O., Gordon E., Dubrovsky A.L., et al. Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule. Hum Mutat 2008, 29(5):728-737.
354. Mendell J.R., Buzin C.H., Feng J., Yan J., Serrano C., Sangani D.S., et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology 2001, 57(4):645-650.
355. Gatta V., Scarciolla O., Gaspari A.R., Palka C., De Angelis M.V., Di Muzio A., et al. Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Hum Genet 2005, 117(1):92-98.
356. Bovolenta M., Neri M., Fini S., Fabris M., Trabanelli C., Venturoli A., et al. A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies. BMC Genomics 2008, 9:572.
357. Hegde M.R., Chin E.L., Mulle J.G., Okou D.T., Warren S.T., Zwick M.E. Microarray-based mutation detection in the dystrophin gene. Hum Mutat 2008, 29(9):1091-1099.
358. del Gaudio D., Yang Y., Boggs B.A., Schmitt E.S., Lee J.A., Sahoo T., et al. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat 2008, 29(9):1100-1107.
359. Multicenter Study Group Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. A multicenter study. JAMA 1992, 267(19):2609-2615.
360. Darras B.T., Koenig M., Kunkel L.M., Francke U. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet 1988, 29(3):713-726.
361. Bonnal R.J., Severgnini M., Castaldi A., Bordoni R., Iacono M., Trimarco A., et al. Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing. Anal Biochem 2010, 406(2):176-184.
362. Almomani R., van der Stoep N., Bakker E., den Dunnen J.T., Breuning M.H., Ginjaar I.B. Rapid and cost effective detection of small mutations in the DMD gene by high resolution melting curve analysis. Neuromuscul Disord: NMD 2009, 19(6):383-390.
363. Aartsma-Rus A., Van Deutekom J.C., Fokkema I.F., Van Ommen G.J., Den Dunnen J.T. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006, 34(2):135-144.
364. Darras B.T., Francke U. Myopathy in complex glycerol kinase deficiency patients is due to 3' deletions of the dystrophin gene. Am J Hum Genet 1988, 43(2):126-130.
365. Kim U.K., Chae J.J., Lee S.H., Lee C.C., Namkoong Y. Molecular diagnosis of Duchenne/Becker muscular dystrophy by polymerase chain reaction and microsatellite analysis. Mol Cells 2002, 13(3):385-388.
366. Abbs S., Roberts R.G., Mathew C.G., Bentley D.R., Bobrow M. Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene. Genomics 1990, 7(4):602-606.
367. Ferreiro V., Szijan I., Giliberto F. Detection of germline mosaicism in two Duchenne muscular dystrophy families using polymorphic dinucleotide (CA)n repeat loci within the dystrophin gene. Mol Diagn 2004, 8(2):115-121.
368. van Essen A.J., Kneppers A.L., van der Hout A.H., Scheffer H., Ginjaar I.B., ten Kate L.P., et al. The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol. J Med Genet 1997, 34(10):805-812.
369. van Essen A.J., Busch H.F., te Meerman G.J., ten Kate L.P. Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands. Hum Genet 1992, 88(3):258-266.
370. Ladwig D., Mowat D., Tobias V., Taylor P.J., Buckley M.F., McNally G., et al. In utero fetal muscle biopsy in the diagnosis of Duchenne muscular dystrophy. Aust NZ J Obstet Gynaecol 2002, 42(1):79-82.
371. Raymond F.L., Whittaker J., Jenkins L., Lench N., Chitty L.S. Molecular prenatal diagnosis: the impact of modern technologies. Prenat Diagn 2010, 30(7):674-681.